Draft Genome Sequence of Carbapenemase-Producing Serratia marcescens Isolated from a Patient with Chronic Obstructive Pulmonary Disease

Sarah Lepuschitz; Sieglinde Sorschag; Burkhard Springer; Franz Allerberger; Werner Ruppitsch

doi:10.1128/genomeA.01288-17

Draft Genome Sequence of Carbapenemase-Producing Serratia marcescens Isolated from a Patient with Chronic Obstructive Pulmonary Disease

Genome Announc. 2017 Nov 16;5(46):e01288-17. doi: 10.1128/genomeA.01288-17.

Authors

Sarah Lepuschitz^{1

2}, Sieglinde Sorschag³, Burkhard Springer⁴, Franz Allerberger⁴, Werner Ruppitsch^{4

5}

Affiliations

¹ Institute of Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Graz, Austria sarah.lepuschitz@ages.at.
² Vienna University of Technology, Research Area of Biochemical Technology, Institute of Chemical, Biological and Environmental Engineering, Vienna, Austria.
³ Department of Hospital Hygiene and Infectious Diseases, Community-Hospital Klagenfurt am Wörthersee, Klagenfurt, Austria.
⁴ Institute of Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Graz, Austria.
⁵ Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.

Abstract

The occurrence of multidrug-resistant Serratia marcescens strains producing metallo-β-lactamases or extended-spectrum β-lactamases represents a serious public health threat. Here, we report the draft genome sequence of a multidrug-resistant carbapenemase-producing Serratia marcescens isolate recovered from the bronchoalveolar lavage specimen of a patient suffering from chronic obstructive pulmonary disease (COPD).